Subgroup identification-based model selection to improve the predictive performance of individualized dosing
- PMID: 38400995
- DOI: 10.1007/s10928-024-09909-8
Subgroup identification-based model selection to improve the predictive performance of individualized dosing
Abstract
Currently, model-informed precision dosing uses one population pharmacokinetic model that best fits the target population. We aimed to develop a subgroup identification-based model selection approach to improve the predictive performance of individualized dosing, using vancomycin in neonates/infants as a test case. Data from neonates/infants with at least one vancomycin concentration was randomly divided into training and test dataset. Population predictions from published vancomycin population pharmacokinetic models were calculated. The single best-performing model based on various performance metrics, including median absolute percentage error (APE) and percentage of predictions within 20% (P20) or 60% (P60) of measurement, were determined. Clustering based on median APEs or clinical and demographic characteristics and model selection by genetic algorithm was used to group neonates/infants according to their best-performing model. Subsequently, classification trees to predict the best-performing model using clinical and demographic characteristics were developed. A total of 208 vancomycin treatment episodes in training and 88 in test dataset was included. Of 30 identified models from the literature, the single best-performing model for training dataset had P20 26.2-42.6% in test dataset. The best-performing clustering approach based on median APEs or clinical and demographic characteristics and model selection by genetic algorithm had P20 44.1-45.5% in test dataset, whereas P60 was comparable. Our proof-of-concept study shows that the prediction of the best-performing model for each patient according to the proposed model selection approaches has the potential to improve the predictive performance of model-informed precision dosing compared with the single best-performing model approach.
Keywords: Genetic algorithm; Model-informed precision dosing; Population pharmacokinetic model; Principal component analysis; k-medoids clustering.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Ewoldt TMJ, Abdulla A, Rietdijk WJR et al (2022) Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial. Intensive Care Med 48:1760–1771. https://doi.org/10.1007/S00134-022-06921-9 - DOI - PubMed - PMC
-
- Neely MN, Kato L, Youn G et al (2018) Prospective trial on the Use of Trough Concentration versus Area under the curve to determine therapeutic vancomycin dosing. Antimicrob Agents Chemother 62. https://doi.org/10.1128/AAC.02042-17
-
- Roggeveen LF, Guo T, Fleuren LM et al (2022) Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock—a two-centre randomised clinical trial. Crit Care 26:1–11. https://doi.org/10.1186/S13054-022-04098-7/TABLES/4 - DOI
-
- Frymoyer A, Schwenk HT, Zorn Y et al (2020) Model-informed Precision Dosing of Vancomycin in Hospitalized Children: implementation and adoption at an academic children’s hospital. Front Pharmacol 11:551. https://doi.org/10.3389/FPHAR.2020.00551/BIBTEX - DOI - PubMed - PMC
-
- He N, Su S, Yan Y et al (2020) The benefit of Individualized Vancomycin Dosing Via Pharmacokinetic Tools: a systematic review and Meta-analysis. Ann Pharmacother 54:331–343. https://doi.org/10.1177/1060028019887363/ASSET/IMAGES/LARGE/10.1177_1060... - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
